US Broker Ratings

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Insights into a 5.86% Potential Upside

Mettler-Toledo International, Inc. (NYSE: MTD), a prominent player in the Diagnostics & Research industry, continues to capture investor attention with its precision instruments and innovative solutions across various sectors. With..

Agilent Technologies (A) Stock Analysis: Promising 21.61% Upside in the Diagnostics & Research Sector

Agilent Technologies, Inc. (NYSE: A), a leader in the healthcare sector’s diagnostics and research industry, presents a compelling opportunity for investors seeking growth and stability. With a robust market cap..

Biogen Inc. (BIIB) Stock Analysis: Exploring Growth Potential Amidst a 2.82% Upside

Biogen Inc. (NASDAQ: BIIB) is a formidable player in the healthcare sector, specializing in the discovery, development, and delivery of therapies for neurological and neurodegenerative diseases. With a market capitalization..

Avantor, Inc. (AVTR) Stock Analysis: Unpacking a Potential 16.55% Upside in the Healthcare Sector

Avantor, Inc. (NYSE: AVTR), a notable player in the healthcare sector, is attracting attention with its specialization in mission-critical products and services that cater to diverse industries including biopharma, healthcare,..

argenx SE (ARGX) Investor Outlook: Exploring a 20% Upside Potential in the Biotech Sector

argenx SE (NASDAQ: ARGX) has become a noteworthy player in the biotechnology sector, offering compelling opportunities for investors with a penchant for high-growth healthcare stocks. Based in the Netherlands, argenx..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A 12.42% Potential Upside in the Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands out as a key player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of approximately $17.99 billion,..

The Cooper Companies, Inc. (COO): Investor Outlook on a Promising 9.54% Upside Potential

The Cooper Companies, Inc. (NYSE: COO), a stalwart in the Healthcare sector specializing in Medical Instruments & Supplies, presents a promising opportunity for investors, showcasing a potential upside of 9.54%...

CVS Health Corporation (CVS) Stock Analysis: Navigating Healthcare with an 18.83% Potential Upside

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector, operating across multiple segments that collectively offer comprehensive health solutions. With a market capitalization of $101.06..

UnitedHealth Group (UNH) Stock Analysis: Growth Potential with 18.21% Upside

UnitedHealth Group Incorporated (NYSE: UNH) stands as a titan in the healthcare sector, boasting a market capitalization of $300.58 billion. For investors looking to tap into the healthcare plans industry,..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Healthcare Giant with a 10.87% Upside Potential

Smith & Nephew SNATS, Inc. (SNN), a prominent player in the healthcare sector, is making waves in the medical devices industry. Headquartered in Watford, United Kingdom, this company has a..

Moderna, Inc. (MRNA) Stock Analysis: Exploring a 17.79% Potential Upside Amidst Revenue Challenges

Investors eyeing the biotechnology sector have their sights set on Moderna, Inc. (NASDAQ: MRNA), a prominent player in the development of messenger RNA (mRNA) medicines. Despite a challenging year marked..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Unveiling a 22.8% Potential Upside in the Biotech Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a heavyweight in the biotechnology industry, is currently captivating investor interest with its promising pipeline of RNA interference therapeutics. With a market capitalization of $52.92..

Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating a 6.16% Upside Potential for Investors

Gilead Sciences, Inc. (NASDAQ: GILD), a towering figure in the healthcare sector, continues to capture investor attention with its formidable presence in the drug manufacturing industry. With a market capitalization..

The Ensign Group, Inc. (ENSG): Investor Outlook with a 17.43% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a notable player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $10.22 billion, this..

Encompass Health (EHC) Stock Analysis: A Healthcare Giant with a Potential 30% Upside

For investors seeking promising opportunities in the healthcare sector, Encompass Health Corporation (NYSE: EHC) presents a compelling case. As a leader in post-acute healthcare services, Encompass Health operates a vast..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 6.43% Potential Upside in the Healthcare Sector

Solventum Corporation (NASDAQ: SOLV), a dynamic player in the healthcare sector, is capturing investor attention with its expansive portfolio and a potential upside of 6.43% as indicated by recent analyst..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Potential 49.69% Upside with Strong Buy Ratings

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leader in the biotechnology sector, continues to capture investor interest with its promising pipeline and robust portfolio of therapies for rare diseases and medical..

DaVita Inc. (DVA) Stock Analysis: Examining Growth Potential Amidst a 26.78% Upside

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector specializing in kidney dialysis services, presents an intriguing case for individual investors seeking growth potential. With a market capitalization..

Exact Sciences Corporation (EXAS) Investor Outlook: Navigating a Promising 2.95% Upside Amid Robust Revenue Growth

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector with a keen focus on diagnostics and research, continues to capture investor attention. With its market capitalization reaching..

Genmab A/S (GMAB) Stock Analysis: Unpacking a Promising 13% Upside Potential in Biotech

Genmab A/S (GMAB), a leading biotechnology company based in Denmark, has been capturing the attention of investors with its robust pipeline of antibody-based therapies targeting cancer and other diseases. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds